3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Colorectal Neoplasms
438
Rectal Neoplasms
209
Colonic Neoplasms
201
Pancreatic Neoplasms
129
Stomach Neoplasms
116
Neoplasm Metastasis
97
Neoplasms
63
Esophageal Neoplasms
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Lymphoma
49
Leukemia
41
Carcinoma, Hepatocellular
40
Adenocarcinoma Of Esophagus
37
Burkitt Lymphoma
33
Adenocarcinoma
29
Cholangiocarcinoma
25
Biliary Tract Neoplasms
22
Carcinoma, Non-Small-Cell Lung
21
Gastrointestinal Neoplasms
20
Lymphoma, Non-Hodgkin
19
Gallbladder Neoplasms
19
Esophageal Squamous Cell Carcinoma
15
Osteosarcoma
14
Bile Duct Neoplasms
14
Unspecified Adult Solid Tumor, Protocol Specific
13
Lymphoma, Large B-Cell, Diffuse
13
Liver Neoplasms
13
Leukemia, Biphenotypic, Acute
13
Ovarian Neoplasms
12
Leukemia, Myeloid, Acute
12
Interventions
adavosertib
5
durvalumab
3
Paclitaxel
3
olaparib
2
ceralasertib
2
Fluorouracil
2
Carboplatin
2
toripalimab
1
sintilimab
1
pembrolizumab
1
factor IX, factor VII, factor X, prothrombin drug combination
1
drug XX Z
1
danvatirsen
1
capivasertib
1
Rifampin
1
Pantoprazole
1
Omeprazole
1
Leucovorin
1
Itraconazole
1
Irinotecan
1
Injections
1
Gemcitabine
1
Doxorubicin
1
Cisplatin
1
AZD0156
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Solid Tumours
×
Leucovorin
×
Clear all
NCT02588105
2022-09-19
AToM
AstraZeneca
Phase 1
Completed
84 enrolled